Alcohol health warning labels are a low-intrusiveness public health measure aiming to inform consumers about alcohol-related health risks, including several cancer types.
AIHTA analyses upcoming cancer medicines and identifies therapies with the potential to significantly impact healthcare delivery and expenditure in the hospital sector.
The AIHTA assessment found no confirmed clinical benefit of amivantamab plus lazertinib compared with osimertinib plus chemotherapy for advanced NSCLC with common EGFR mutations. At the same time, the therapy is associated with higher costs and additional organisational requirements.
What measures can help protect children and young people from the potential risks of social media? A recent AIHTA analysis shows that there is currently no robust evidence to reliably demonstrate the effectiveness of specific regulatory approaches. This makes ethical considerations, awareness-raising, and accompanying evaluation all the more important.
How effective is wheal therapy for musculoskeletal pain? AIHTA has assessed the benefits, safety, and organisational aspects of this treatment and reviewed recommendations from international clinical guidelines.
